Literature DB >> 8563172

Cloning of the murine homolog of the leukemia-associated PML gene.

A D Goddard1, J Q Yuan, L Fairbairn, M Dexter, J Borrow, C Kozak, E Solomon.   

Abstract

PML, a Ring-finger protein, participates in the disruption of normal myeloid differentiation when fused to the retinoic acid receptor alpha (RAR alpha) by the translocation between chromosomes (Chrs) 15 and 17 in acute promyelocytic leukemia (APL). As an initial step in the characterization of PML in species other than human, a murine cDNA clone of the PML gene was isolated and sequenced, and the intron/exon organization of the murine locus determined. The predicted amino acid sequence of the mouse PML protein shows 80% similarity to that of its human homolog. However, the mouse and human proteins show greater than 90% similarity in the proposed functional domains of the proteins. Despite its role in the etiology of APL, PML expression is not detectably altered during granulocytic differentiation in a murine in vitro system. Chromosomal localization of the Pml locus by somatic cell hybrids and by linkage analysis indicates that the gene maps to a region of mouse Chr 9 with known linkage homology to the region on human Chr 15q to which PML has been localized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563172     DOI: 10.1007/bf00354296

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  27 in total

1.  Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms.

Authors:  M Fagioli; M Alcalay; P P Pandolfi; L Venturini; A Mencarelli; A Simeone; D Acampora; F Grignani; P G Pelicci
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

2.  The role of hemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells.

Authors:  C M Heyworth; T M Dexter; O Kan; A D Whetton
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

3.  Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors.

Authors:  E Spooncer; C M Heyworth; A Dunn; T M Dexter
Journal:  Differentiation       Date:  1986       Impact factor: 3.880

4.  The mouse homolog of the Gibbon ape leukemia virus receptor: genetic mapping and a possible receptor function in rodents.

Authors:  M C Adamson; J Silver; C A Kozak
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.

Authors:  P P Pandolfi; F Grignani; M Alcalay; A Mencarelli; A Biondi; F LoCoco; F Grignani; P G Pelicci
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

7.  Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients.

Authors:  J P Geng; J H Tong; S Dong; Z Y Wang; S J Chen; Z Chen; A Zelent; R Berger; C J Larsen
Journal:  Leukemia       Date:  1993-01       Impact factor: 11.528

8.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

9.  Novel myosin heavy chain encoded by murine dilute coat colour locus.

Authors:  J A Mercer; P K Seperack; M C Strobel; N G Copeland; N A Jenkins
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

10.  Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.

Authors:  P Kastner; A Perez; Y Lutz; C Rochette-Egly; M P Gaub; B Durand; M Lanotte; R Berger; P Chambon
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  10 in total

1.  Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.

Authors:  S Tsuzuki; M Towatari; H Saito; T Enver
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Assembly dynamics of PML nuclear bodies in living cells.

Authors:  Peter Brand; Thorsten Lenser; Peter Hemmerich
Journal:  PMC Biophys       Date:  2010-03-05

3.  Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes.

Authors:  Sunwha Cho; Jung Sun Park; Yong-Kook Kang
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

4.  Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.

Authors:  D B Zimonjic; J L Pollock; P Westervelt; N C Popescu; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.

Authors:  K L Borden; E J Campbell Dwyer; M S Salvato
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes.

Authors:  Osamu Udagawa; Ayaka Kato-Udagawa; Seishiro Hirano
Journal:  Biol Open       Date:  2022-06-06       Impact factor: 2.643

7.  A role for Groucho tetramerization in transcriptional repression.

Authors:  G Chen; P H Nguyen; A J Courey
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  SnoN functions as a tumour suppressor by inducing premature senescence.

Authors:  Deng Pan; Qingwei Zhu; Kunxin Luo
Journal:  EMBO J       Date:  2009-09-10       Impact factor: 11.598

9.  PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.

Authors:  P Wimmer; J Berscheminski; P Blanchette; P Groitl; P E Branton; R T Hay; T Dobner; S Schreiner
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

10.  PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.

Authors:  Roger D Everett; Sabine Rechter; Peer Papior; Nina Tavalai; Thomas Stamminger; Anne Orr
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.